Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study

OBJECTIVES: To identify a therapeutic target interval for certolizumab pegol drug levels and examine the influence of anti-drug antibodies in patients with inflammatory joint diseases. METHODS: Certolizumab pegol and anti-drug antibody levels were measured in serum samples collected after 3 months o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Gehin, Johanna Elin, Goll, Guro Løvik, Warren, David John, Syversen, Silje Watterdal, Sexton, Joseph, Strand, Eldri Kveine, Kvien, Tore Kristian, Bolstad, Nils, Lie, Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883678/
https://ncbi.nlm.nih.gov/pubmed/31783773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-2009-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados